CRP and cancer: More than 10 years ago, the first study reported that an elevated C-reactive protein level, a commonly used surrogate marker indicating the degree of systemic inflammatory response, is predictive for the duration of cancer-specific and non-cancer survival in patients suffering from colorectal, gastric, breast, or lung cancer.114